FintastIQ
Book a Consultation

Pricing / pe value creation

Private Equity Value Creation, Grounded in Data

· 2025-04-09

Every operating partner has a value creation thesis. Most of them were written before anyone looked at the actual transaction data. The thesis says something about revenue growth, margin expansion, and go-to-market efficiency. The data says something much more specific: where exactly the money is leaking, at what rate, from which customer segments, and since when. The gap between the thesis and the data is where value creation either happens or doesn't.

The Financial Exposure

When operating partners rely on benchmarks and management instinct instead of transaction-level data, two things happen. First, they invest in the wrong interventions. Second, they don't know it until the data room opens for the next transaction.

A PE-backed (private equity) software company at $68M annual recurring revenue (ARR) with a standard 100-day plan focused on sales headcount and go-to-market (GTM) expansion. The operating partner had seen this pattern work in three prior portfolio companies. Eighteen months after acquisition, ARR was $79M. Respectable. But the waterfall analysis done in preparation for the next round showed that effective discount rates had expanded by 7 points during the expansion, and net revenue retention (NRR) had slipped from 108% to 101%. New logo growth masked structural commercial deterioration.

The interventions that would have mattered most, pricing governance, renewal operations, deal desk structure, were never activated because nobody looked at the data that would have pointed to them. The operating partner was working from experience. The data was sitting in the CRM.

The Playbook

Step 1: Pull the commercial diagnostic before you finalize the 100-day plan. Three data pulls: the pocket price waterfall (list to invoice across all deals in the last 18 months), NRR cohorted by acquisition year, and tier mix versus deal size distribution. These three pulls take two to three weeks and cost almost nothing. They'll tell you more than a 40-slide commercial due diligence deck.

Step 2: Rank interventions by P&L impact, not by effort. Operating partners tend to gravitate toward sales structure and headcount changes because those interventions are familiar and feel decisive. But pricing governance, discount policy, deal desk thresholds, renewal pricing structure, consistently delivers higher P&L impact per dollar of management time than any headcount change. Run the math on your specific company's numbers before you decide where to focus.

Step 3: Instrument the commercial model so you can see drift in real time. The value creation thesis dies quietly when nobody measures it monthly. Set four commercial health metrics and review them in every board meeting: effective discount rate (all concessions, not just the CRM discount field), NRR by cohort, average deal size by segment, and rep-level price realization. If any of these moves in the wrong direction for two consecutive months, you catch it early enough to correct it.

The Breakdown

A PE firm's operating partner took the helm at a $28M ARR vertical SaaS company 14 months post-acquisition. The management team had reported consistent 18% growth. The operating partner focused the first 90 days on marketing spend and sales hiring.

A data pull at month 16 showed something the management reports had never surfaced. The top decile of customers by ARR had an average effective concession rate of 43%. These were the accounts the sales team was proudest of landing. They were also the accounts most likely to churn at renewal because they'd been priced below their actual contract commitments once all term extensions and bundled concessions were counted.

Before: $28M ARR, 16% reported growth, 43% effective concession rate on top-decile accounts, management reporting showing healthy pipeline. After (commercial diagnostic completed in month 18): Deal desk governance implemented, top-decile account renewal playbook rebuilt, 11% improvement in realized revenue on the following renewal cycle without adding a single new logo.

Your Week Ahead

Ask your portfolio company CFO for the closed-won deal data from the last 18 months with every concession type broken out, not just the discount field. If the CFO can produce it in one day, your commercial data infrastructure is solid. If it takes a week and requires a spreadsheet reconciliation, you've just found your first value creation opportunity.

Assess Your Commercial Health

Related reading: How to Measure the ROI of Private Equity Value Creation and How to Measure the ROI of Commercial Due Diligence.

Frequently Asked Questions

Where is the fastest commercial value creation opportunity in a PE portfolio company?
Pricing improvement consistently outpaces other commercial levers. A 1% improvement in realized price generates a 10 to 15% improvement in operating profit for a typical software business. That leverage ratio makes pricing the highest-ROI intervention available to most operating partners in the first 12 months post-acquisition.
How do you use transaction data to find value creation opportunities in a PE-backed company?
Start with the pocket price waterfall: total concession rates by segment, rep, and deal size. Then look at NRR cohorted by acquisition vintage. Then examine tier mix versus willingness-to-pay data. These three data pulls usually surface more opportunity than a standard commercial due diligence ever does.

Find out where your commercial gaps are.

Take the Free Assessment →